| Product Code: ETC5300860 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Burkina Faso`s pharmaceutical import market in 2024 continued to be dominated by key exporters such as India, France, Ghana, Morocco, and China. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth spurt in 2024 with a 10.19% increase from the previous year. The High Herfindahl-Hirschman Index (HHI) suggests a market concentration among these top exporting countries. This data indicates a dynamic pharmaceutical import landscape in Burkina Faso, with potential opportunities for market expansion and diversification in the coming years.

By 2027, the Pharmaceuticals market in Burkina Faso is anticipated to reach a growth rate of 9.98%, as part of an increasingly competitive Africa region, where Egypt remains at the forefront, supported by South Africa, Ethiopia, Algeria and Nigeria, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Pharmaceuticals Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Pharmaceuticals Market - Industry Life Cycle |
3.4 Burkina Faso Pharmaceuticals Market - Porter's Five Forces |
3.5 Burkina Faso Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Burkina Faso Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Burkina Faso Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Burkina Faso Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Burkina Faso Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Burkina Faso Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government spending on healthcare infrastructure and services in Burkina Faso |
4.2.2 Growing prevalence of chronic diseases and infectious illnesses driving demand for pharmaceutical products |
4.2.3 Rising awareness and healthcare literacy among the population leading to increased healthcare-seeking behavior |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services and medicines in rural areas of Burkina Faso |
4.3.2 High prevalence of counterfeit drugs impacting the reputation and trust in pharmaceutical products |
4.3.3 Regulatory challenges and bureaucratic hurdles affecting market entry and operations for pharmaceutical companies |
5 Burkina Faso Pharmaceuticals Market Trends |
6 Burkina Faso Pharmaceuticals Market Segmentations |
6.1 Burkina Faso Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.3 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Burkina Faso Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Burkina Faso Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Burkina Faso Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Burkina Faso Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Burkina Faso Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Burkina Faso Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Burkina Faso Pharmaceuticals Market Export to Major Countries |
7.2 Burkina Faso Pharmaceuticals Market Imports from Major Countries |
8 Burkina Faso Pharmaceuticals Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities equipped with essential medicines |
8.2 Average wait time for patients to access required pharmaceutical products |
8.3 Number of reported incidents related to counterfeit drugs in the pharmaceutical market |
9 Burkina Faso Pharmaceuticals Market - Opportunity Assessment |
9.1 Burkina Faso Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Burkina Faso Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Burkina Faso Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Burkina Faso Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Burkina Faso Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Burkina Faso Pharmaceuticals Market - Competitive Landscape |
10.1 Burkina Faso Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |